0.5568
前日終値:
$0.5246
開ける:
$0.547
24時間の取引高:
1.56M
Relative Volume:
1.11
時価総額:
$50.01M
収益:
$153.73M
当期純損益:
$-106.79M
株価収益率:
-0.3128
EPS:
-1.78
ネットキャッシュフロー:
$-115.93M
1週間 パフォーマンス:
-6.58%
1か月 パフォーマンス:
-27.29%
6か月 パフォーマンス:
-84.68%
1年 パフォーマンス:
-84.64%
Sutro Biopharma Inc Stock (STRO) Company Profile
名前
Sutro Biopharma Inc
セクター
電話
650-392-8412
住所
111 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA
STRO を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
STRO
Sutro Biopharma Inc
|
0.557 | 50.01M | 153.73M | -106.79M | -115.93M | -1.78 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
473.75 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
558.78 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
594.54 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
230.40 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
228.75 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Sutro Biopharma Inc Stock (STRO) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2025-03-17 | ダウングレード | H.C. Wainwright | Buy → Neutral |
2025-03-14 | ダウングレード | BofA Securities | Buy → Underperform |
2025-03-14 | ダウングレード | Citizens JMP | Mkt Outperform → Mkt Perform |
2025-03-14 | ダウングレード | Wedbush | Outperform → Neutral |
2024-05-08 | 開始されました | BofA Securities | Buy |
2023-11-09 | 開始されました | Deutsche Bank | Buy |
2023-10-06 | 開始されました | Oppenheimer | Outperform |
2023-03-21 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
2022-08-18 | 再開されました | Wells Fargo | Overweight |
2021-06-18 | 開始されました | H.C. Wainwright | Buy |
2020-12-03 | 開始されました | Stifel | Buy |
2020-09-02 | 開始されました | Jefferies | Buy |
2020-07-16 | 開始されました | Wells Fargo | Overweight |
2020-01-13 | 開始されました | SunTrust | Buy |
2019-10-07 | 開始されました | BTIG Research | Buy |
2019-07-18 | 開始されました | Deutsche Bank | Buy |
2019-04-29 | 開始されました | H.C. Wainwright | Buy |
2018-10-22 | 開始されました | JMP Securities | Mkt Outperform |
2018-10-22 | 開始されました | Piper Jaffray | Overweight |
2018-10-22 | 開始されました | Wedbush | Outperform |
すべてを表示
Sutro Biopharma Inc (STRO) 最新ニュース
Benign Growth For Sutro Biopharma, Inc. (NASDAQ:STRO) Underpins Stock's 36% Plummet - simplywall.st
Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges By Investing.com - Investing.com South Africa
Sutro Biopharma stock hits 52-week low at $0.54 amid market challenges - Investing.com Canada
Sutro Biopharma, Inc. (NASDAQ:STRO) Stock Holdings Boosted by American Century Companies Inc. - Defense World
Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace
Sutro Biopharma announces board member departure By Investing.com - Investing.com Canada
Sutro Biopharma announces board member departure - Investing.com Australia
Sei Investments Co. Takes Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Changing FacesPharma and Biotech HiresMarch 2025 - pharmaphorum
Prudential Financial Inc. Increases Stock Position in Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Thrivent Financial for Lutherans Acquires Shares of 97,096 Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges By Investing.com - Investing.com South Africa
Sutro Biopharma stock hits 52-week low at $0.58 amid market challenges - Investing.com
Sutro Biopharma, Inc. (NASDAQ:STRO) Receives Average Rating of “Hold” from Analysts - Defense World
Sutro Biopharma stock hits 52-week low at $0.76 amid sharp decline - Investing.com Australia
Sutro Biopharma stock hits 52-week low at $0.76 amid sharp decline By Investing.com - Investing.com South Africa
Connor Clark & Lunn Investment Management Ltd. Sells 110,734 Shares of Sutro Biopharma, Inc. (NASDAQ:STRO) - Defense World
Sutro Biopharma lays off dozens of employees in ‘strategic portfolio review’ - MSN
Biotech company based in Peninsula laying off 90% of staff - MSN
HC Wainwright Expects Stronger Earnings for Sutro Biopharma - Defense World
Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle
The Escalator: Stoke Therapeutics, Merck, Sutro Biopharma and more - Medical Marketing and Media
Sutro Biopharma rises after market hours on portfolio review, restructuring - MSN
Sutro Biopharma’s (STRO) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World
Sutro Biopharma stock rating downgraded at H.C. Wainwright - Investing.com Australia
Sutro Biopharma stock rating downgraded at H.C. Wainwright By Investing.com - Investing.com Canada
This Li Auto Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday - Benzinga
HC Wainwright Downgrades Sutro Biopharma to Neutral From Buy, Price Target is $2 -March 17, 2025 at 08:33 am EDT - Marketscreener.com
Oppenheimer Downgrades Sutro Biopharma to Market Perform From Outperform -March 17, 2025 at 07:57 am EDT - Marketscreener.com
Deutsche Bank Adjusts Sutro Biopharma Price Target to $5 From $10, Maintains Buy Rating - Marketscreener.com
Sutro Biopharma’s SWOT analysis: ADC developer’s stock faces pivotal shift By Investing.com - Investing.com South Africa
Sutro Biopharma’s SWOT analysis: ADC developer’s stock faces pivotal shift - Investing.com
Sutro Biopharma (NASDAQ:STRO) Cut to Market Perform at Citizens Jmp - Defense World
Array Technologies, Nextracker, Sutro Biopharma - TradingView
Sutro Biopharma (STRO) Expected to Announce Quarterly Earnings on Monday - Defense World
Sutro Biopharma (NASDAQ:STRO) Cut to Neutral at Wedbush - Defense World
Sutro Biopharma (NASDAQ:STRO) Cut to “Underperform” at Bank of America - Defense World
Sutro Biopharma Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance UK
Sutro Biopharma: Revolutionizing Cancer Treatment with Precision Therapeutics - Apna Kal
Sutro Biopharma Inc (STRO) 財務データ
収益
当期純利益
現金流量
EPS
Sutro Biopharma Inc (STRO) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
NEWELL WILLIAM J | CEO |
Mar 05 '25 |
Option Exercise |
0.00 |
18,750 |
0 |
299,239 |
FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
99,027 |
ALBINI EDWARD C | CFO AND SECRETARY |
Mar 05 '25 |
Option Exercise |
0.00 |
8,750 |
0 |
135,675 |
FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 04 '25 |
Option Exercise |
0.00 |
9,125 |
0 |
94,025 |
NEWELL WILLIAM J | CEO |
Mar 04 '25 |
Option Exercise |
0.00 |
31,125 |
0 |
291,625 |
Chung Jane | PRESIDENT AND COO |
Mar 04 '25 |
Option Exercise |
0.00 |
7,875 |
0 |
100,642 |
ALBINI EDWARD C | CFO AND SECRETARY |
Mar 01 '25 |
Option Exercise |
0.00 |
25,125 |
0 |
131,868 |
Chung Jane | PRESIDENT AND COO |
Mar 01 '25 |
Option Exercise |
0.00 |
31,875 |
0 |
102,217 |
FITZPATRICK LINDA A | CHIEF PEOPLE & COMM. OFFICER |
Mar 01 '25 |
Option Exercise |
0.00 |
20,275 |
0 |
93,227 |
Gerber Hans-Peter | CHIEF SCIENTIFIC OFFICER |
Mar 01 '25 |
Option Exercise |
0.00 |
11,250 |
0 |
35,370 |
大文字化:
|
ボリューム (24 時間):